Gadolinium-based contrast agents (GBCAs) are commonly used for enhancement in MR
imaging and have long been considered safe when administered at recommended doses …

Although Langerhans cell histiocytosis (LCH) is a familiar entity to most radiologists and to
pediatric radiologists in particular, it is but one of a group of disorders caused by the …

The classification and pathological mechanisms of many central nervous system
inflammatory diseases remain uncertain. In this article we report eight patients with a …

Background Diabetes insipidus (DI) is the most frequent central nervous system (CNS)‐
related permanent consequence in Langerhans cell histiocytosis (LCH), which mostly …

Multisystem Langerhans cell histiocytosis (MS-LCH) is associated with high mortality when
patients have risk organ involvement (RO+) or are younger than 2 years. In an international …

Langerhans cell histiocytosis (LCH) is a rare disease of the monocyte-macrophage system.
The clinical presentation ranges from a single bone lesion to widespread multiorgan …

Cavernous sinuses are paired interconnected venous plexuses situated in the floor of the
middle cranial fossa on either side of the sella turcica and sphenoid sinus. They are lined by …

Calvarial lesions are often asymptomatic and are usually discovered incidentally during
computed tomography or magnetic resonance imaging of the brain. Calvarial lesions can be …

BACKGROUND Central nervous system Langerhans cell histiocytosis (CNS‐LCH) brain
involvement may include mass lesions and/or a neurodegenerative disease (LCH‐ND) of …

CNS involvement in Langerhans cell histiocytosis (LCH) is a rare but potentially devastating
disorder. Different types of involvement have been described by MRI. CNS changes can …